Found 6 matching trials
A Phase 1b/2 Study in Asian Subjects With Non-Small Cell Lung Cancer
PHASE1During Phase 1b portion, there will be a dose-escalation of AV-299 (formerl...
Location
Investigational Site 1
A Pharmacodynamic Study of AV-299 (Formerly SCH 900105) in Subjects With Advanced Solid Tumors Who Have Liver Metastases
PHASE1A pharmacodynamic study to evaluate the effect of AV-299 on exploratory pha...
Location
Investigational Site 1
Ficlatuzumab w/wo Cetuximab in Patients w/Cetuximab-Resistant, Recurrent or Metastatic Head/Neck Squamous Cell Carcinoma
PHASE2This randomized phase II trial studies how well ficlatuzumab with or withou...
Location
The University of Arizona Cancer Center
Protocol to Allow Continued Access of Ficlatuzumab to P05538 Patient
N/AProtocol to Allow Continued Access of Ficlatuzumab to P05538 Patient...
Status
No Longer Available
A Phase 1 Dose-Escalation Study in Advanced Solid Tumors, Lymphomas or Multiple Myeloma
PHASE1Phase 1 study to determine safety, tolerability, dose-limiting toxicities (...
Location
Investigational Site 2
SCH-900105 in Recurrent Glioblastoma
PHASE1The goal of this clinical research study is to find the highest tolerable d...
Location
Multiple Locations